An application of gene comparative image for predicting the effect on replication ratio by HBV virus gene missense mutation

Journal of Theoretical Biology

Volumn 235, Issue 4, 2005, Pages 555-565

  Xiao, Xuan ^a,b   Shao, Shihuang ^a   Ding, Yongsheng ^a   Huang, Zhengde ^a   Chen, Xiaojing ^a   Chou, Kuo Chen ^a,c  

^a DONGHUA UNIVERSITY   (China)

^b JINGDEZHEN CERAMIC INSTITUTE   (China)

^c GORDON LIFE SCIENCE INSTITUTE   (United States)

Author keywords

Cellular automata; Hepatitis B virus; Missense mutation; Replication ratio

Indexed keywords

HEPATITIS; MUTATION; VIRUS;

ARTICLE; AUTOMATION; COMPARATIVE STUDY; COMPUTER MODEL; DATA BASE; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENOMICS; HEPATITIS B VIRUS; IMAGING; MISSENSE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIMULATION; THEORETICAL MODEL; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MUTATION, MISSENSE; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 20344364176     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtbi.2005.02.008     Document Type: Article

References (75)

1. O. Akihiko, I. Tetsuya, Y. Kentaro, Y. Ryugo, F. Yoshitaka, and K. Shinichi Mutation at codon 130 in hepatitis B virus(HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers, [J] Gastroenterology 36 2001 103 110
2. M.I. Allen, M. Deslauriers, C.W. Andrews, G.A. Tipples, K.A. Walters, D.L. Tyrrell, N. Brown, and L.D. Condreay Identification and characterization of mutations in hepatitis B virus resistant to lamivudine clinical investigation group Hepatology 27 1998 1670 1677
3. A. Bartholomeusz, R.F. Schinazi, and S.A. Locarnini Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease Viral Hepatitis Rev. 4 1998 167 187
4. T.F. Baumert, A. Marrone, J. Vergalla, and T.J. Liang Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression J. Virol. 72 1998 6785 6795
5. H.E. Blum, E. Galun, and T.J. Liang Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication J. Virol. 65 4 1991 1836 1842
6. S.H. Bryant, and S.F. Altschul Statistics of sequence-structure threading Curr. Opin. Struct. Biol. 5 1995 236 244
7. S.H. Bryant, and C.E. Lawrence An empirical energy function for threading protein sequence through the folding motif Proteins 16 1993 92 112
8. V.E. Buckwold, Z. Xu, M. Chen, T.S. Yen, and J.H. Ou Effects of naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication J. Virol. 70 1996 5845 5851
9. V.E. Buckwold, Z. Xu, T.S. Yen, and J.H. Ou Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication J. Gen. Virol. 78 1997 2055 2065
10. K.C. Chou Energy-optimized structure of antifreeze protein and its binding mechanism Journal of Molecular Biology 223 1992 509 517
11. K.C. Chou Review: structural bioinformatics and its impact to biomedical science Curr. Med. Chem. 11 2004 2105 2134
12. K.C. Chou, and L. Carlacci Energetic approach to the folding of a/β barrels Proteins: Struct. Funct. Genet. 9 1991 280 295
13. K.C. Chou, and C.T. Zhang Review: prediction of protein structural classes Crit. Rev. Biochem. Mol. Biol. 30 1995 275 349
14. K.C. Chou, M. Pottle, G. Nemethy, Y. Ueda, and H.A. Scheraga Structure of beta-sheets: origin of the right-handed twist and of the increased stability of antiparallel over parallel sheets J. Mol. Biol. 162 1982 89 112
15. K.C. Chou, G. Nemethy, and H.A. Scheraga Review: energetics of interactions of regular structural elements in proteins Accounts Chem. Res. 23 1990 134 141
16. W.E. Delaney IV., H. Yang, C.E. Westland, K. Das, E. Arnold, C.S. Gibbs, M.D. Miller, and S. Xiong The Hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro J. Virol. 77 2003 11833 11841
17. T. Ehata, M. Omata, W.L. Chuang, O. Uokosuka, Y. Ito, K. Hosoda, and M. Ohto Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis J. Clin. Invest. 91 1993 1206 1213
18. A. Erhardt, U. Reineke, D. londin, W. Gerlich, O. Adams, T. Heintges, C. Niederau, and D. Haussinger Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B Hepatology 31 1999 716 725
19. L. Fu, and Y.C. Cheng Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in l(-)SddC (3TC)resistance Biochem. Pharmacol. 55 1998 1567 1572
20. M.H. Gang, Y.I. Lee, D.J. Suh, and J.H. Lee Gradual accumulation of mutations in precore core region of HBV in patients with chronic active hepatitis: implications of clustering changes in a small region of the HBV core region J. Med. Virol. 48 1996 38 46
21. S. Gunther, S. Baginski, H. Kissel, P. Reinke, H. Kruger, H. Will, and H. Meisel Accumulation and persistence of hepatitis B virus core gene deletion nutants in renal transplant patients are associated with end-stage liver disease Hepatology 24 1996 751 758
22. S. Gunther, L. Fisher, J. Pult, M. Sterneck, and H. Will Naturally occurring variants of hepatitis B virus J. Virol. 69 1999 5437 5444
23. K. Hasegawa, J. Huang, S.A. Rogers, H.E. Blum, and T.J. Liang Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis J. Virol. 68 3 1994 1651 1659
24. J.L. Hou, and Z.H. Wang B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin a1 and famciclovir in Chinese asymptomatic HBV carriers Nat. Med. J. China 80 8 2000 574 576
25. T. Imamichi, S.C. Berg, H. Imamichi, J.C. Lopez, J.A. Metcalf, and J. Falloon Relative replication fitness of a high-level 3′-azido-3′- deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr→Gly) at codon 69 J. Virol. 74 2000 10958 10964
26. D.T. Jones Progress in protein structure prediction Curr. Opin. Struct. Biol. 7 1997 377 387
27. D.T. Jones, and J.M. Thornton Potential energy functions for threading Curr. Opin. Struct. Biol. 6 1996 210 216
28. J. Kao, P. Chen, M. Lai, and D. Chen Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers Gastroenterology 124 2003 327 334
29. T. Kalinina, A. Riu, L. Fisher, H. Will, and M. Sterneck A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatits Hepatology 34 2001 385 394
30. M. Karplus, and G.A. Petsko Molecular dynamics simulations in biology Nature 347 1990 631 639
31. M. Koschel, D. Oed, T. Gerelsaikhan, R. Thomssen, and V. Bruss Hepatitis B virus core gene mutations which block nucleocapsid envelopment J. Virol. 74 2000 1 7
32. S.K. Ladner, T.J. Miller, and R.W. King The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2′-deoxy-3′- thiacytidine and a reduced ability to synthesize viral DNA Antimicrob. Agents Chemother. 42 8 1998 2128 2131
33. C. Lamberts, M. Nassal, I. Velhagen, H. Zentgraf, and C.H. Schroder Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis J. Virol. 67 7 1993 3756 3762
34. S. Le Pogam, T.T. Yuan, G.K. Sahu, S. Chatterjee, and C. Shih Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein J. Virol. 74 19 2000 9099 9105
35. Y.F. Liaw Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B Antiviral Chem. Chemother. 12 2001 67 71
36. Y.F. Liaw, R.N. Chien, C.T. Yeh, S.L. Tsai, and C.M. Chu Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy Hepatology 30 1999 567 572
37. X. Lin, Z.H. Yuan, L. Wu, J.P. Ding, and Y.M. Wen A single amino acid in the reverse transcriptase domain of Hepatitis B virus affects virus replication efficiency J. Virol. 75 23 2001 11823 11833
38. R. Ling, and T.J. Harrison Functional analysis of mutations conferring lamivudine resistance on hepatitis B virus J. Virol. 80 1999 601 606
39. R. Ling, D. Mutimer, M. Ahmed, E. Boxall, E. Elias, M. Dusheiko, and T.J. Harrison Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with 3TC Hepatology 24 1996 711 713
40. S. Locarnini Hepatitis B viral resistance: mechanisms and diagnosis J. Hepatol. 39 2003 124 132
41. J.R. Lu, W. Jiang, and J.Y. Xue Relationship between HBV c gene promoter gene mutation and serum HBeAg and HBV DNA contents Acad. J. Sec. Mil. Med. Univ. 23 12 2002 1348 1350
42. C. Mayerat, A. Mantegani, F. Spertini, and P.C. Frei Mutations in the basal core promoter and precore/core gene of hepatitis B virus in patients with chronic active but not acute hepatitis B Eur. J. Clin. Microbiol. Infect. Dis. 18 12 1999 871 878
43. P.K. Mehta, J. Heringa, and P. Argos A simple and fast approach to prediction of protein secondary structure from multiply aligned sequences with accuracy above 70% Protein Sci. 4 1995 2517 2525
44. M. Melegari, P.P. Scaglioni, and J.R. Wands Hepatitis B virus mutants associated with 3TC and famciclivir administrations are replication defective Hepatology 27 1998 628 633
45. K. Moriyama, H. Okamoto, F. Tsuda, and M. Mayumi Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infectious J. Virol. 226 2 1996 269 280
46. R. Najmanovich, J. Kuttner, V. Sobolev, and M. Edelman Side-chain flexibility in proteins upon ligand binding 39 2000 261 268
47. M.J. Ondrechen, J.G. Clifton, and D. Ringe A simple computational predictor of enzyme function from structure Proc. Natl. Acad. Sci. USA 98 2001 12473 12478
48. R. Perrillo, E. Schiff, E. Yoshida, A. Statler, K. Hirsch, T. Wright, K. Gutfreund, P. Lamy, and A. Murray Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants Hepatology 32 2000 129 134
49. M. Picardi, F. Pane, C. Quintarelli, A. De Renzo, and A. Del Giudice Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations Haematologica 88 2003 1296 1303
50. C. Pichoud, B. Seigneres, Z.R. Wang, C. Trepo, and F. Zoulim Transient selection of hepatitis B virus polymerase gene mutant associated with decreased replication capacity and famciclovir resistance Hepatology 29 1 1999 230 237
51. P. Preikschat, H. Meisel, H. Will, and S. Gunther Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions J. Gen. Virol. 80 1999 2685 2691
52. I. Pult, T. Chouard, S. Wieland, R. Klemenz, M. Yaniv, and H. Blum A hepatitis B virus mutant with a new hepatocyte nuclear factor binding site emerging in transplant-transmitted fulminant hepatitis B Hepatology 25 1997 1507 1515
53. S. Sato, K. Suzuki, Y. Akahane, K. Akamatsu, K. Akiyama, K. Yunomura, F. Tsuda, T. Tanaka, H. Okamoto, Y. Miyakawa, and M. Mayumi Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis Ann. Intern. Med. 122 1995 241 248
54. P.P. Scaglioni, M. Melegari, and J.R. Wands Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame Virology 233 1997 374 381
55. S. Schulze-Kremer Genetic algorithms and protein folding Methods Mol. Biol. 143 2000 175 222
56. F. Silvestri, A. Ermacora, A. Sperotto, F. Patriarca, F. Zaja, and D. Damiani Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation J. Hepatol. 36 2002 464 473
57. R. Srinivasan, and G.D. Rose LINUS: a hierarchic procedure to predict the fold of a protein Proteins: Struct. Funct. Genet. 22 1995 81 99
58. F.M. Suk, M.H. Lin, M. Newman, S. Pan, S.H. Chen, J.D. Liu, and C. Shih Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus J. Virol. 76 23 2002 12069 12077
59. K.O. Suzane, K. Naoya, S. Yasushi, K. Jun, G. Tadashi, F.S. Raymond, J.C. Flair, and O. Masao The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance J. Clin. Invest. 107 4 2001 449 455
60. G.A. Tipples, M.M. Ma, K.P. Fischer, V.G. Bain, N.M. Kneteman, and K.L.J. Tyrrell Mutation in HBV RNA-dependent DNA polymerase confers resistance to 3TC in vitro Hepatology 24 1996 714 717
61. M. Wang, J.S. Yao, Z.D. Huang, Z.J. Xu, G.P. Liu, H.Y. Zhao, X.Y. Wang, J. Yang, Y.S. Zhu, and K.C. Chou A new nucleotide-composition based fingerprint of SARS-CoV with visualization analysis Medicinal Chemistry 1 2005 39 47
62. S. Wolfram Cellular automation fluid: basic theory J. Statist. Phys. 45 1986 471
63. S. Wolfram A New Kind of Science 2002 Wolfram Media, Inc. Champaign, IL
64. X. Xiao, S. Shao, Y. Ding, Z. Huang, X. Chen, and K.C. Chou Using cellular automata to generate image representation for biological sequences Amino Acids 28 2005 29 35
65. X. Xiong, H. Yang, C. Westland, J.J. Toole, and C.S. Gibbs Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro Hepatology 28 1998 1669 1673
66. X. Xiong, H. Yang, C. Westland, R. Zou, and C. Gibbs In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance Hepatology 31 2000 219 224
67. A.S. Yang, and B. Honig Free energy determinants of secondary structure formatin: I Alpha-Helices 252 1995 351 365
68. C.T. Yeh, R.N. Chien, C.M. Chu, and Y.F. Liaw Clearance of the original hepatitis B virus YMDD motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy Hepatology 31 2000 1318 1326
69. T.T. Yuan, and P.C. Tai Subtype-independent immature secretion and subtype-dependent replication deficiency of highly frequent, naturally occurring mutation of human hepatitis B virus core antigen J. Virol. 73 1999 10122 10128
70. T.T. Yuan, A. Faruqi, J.W.K. Shih, and C. Shih The mechanism of natural occurrence of two closely linked HBV precore predominant mutations Virology 211 1995 144 156
71. T.T. Yuan, M.H. Lin, S.M. Qiu, and C. Shih Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation J. Virol. 72 1998 2168 2176
72. T.T. Yuan, P.C. Tai, and C. Shih A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L) J. Virol. 74 2000 4929 4932
73. G.P. Zhou An intriguing controversy over protein structural class prediction J. Protein Chem. 17 1998 729 738
74. G.P. Zhou, and N. Assa-Munt Some insights into protein structural class prediction Proteins: Struct. Funct. Genet. 44 2001 57 59
75. G.P. Zhou, and K. Doctor Subcellular location prediction of apoptosis proteins Proteins: Struct. Funct. Genet. 50 2003 44 48